Paid Clinical Trials for Metastatic Cancer

Showing 21 – 37 of 37 results

Definitive Radiation for High-Risk Spine Metastases

by CTG

in Metastatic Breast Cancer, Metastatic Cancer, Metastatic Lung Cancer, Metastatic Tumor, Metastatic Tumor of Bone

Other

New York

Deadline:

05/31/2026

A Study of MGC026 in Participants With Advanced Solid Tumors

by CTG

in Non Small Cell Lung Cancer, Metastatic Cancer, Advanced Cancer, Advanced Solid Tumor, Squamous Cell Carcinoma of Head and Neck

Other

California

Deadline:

10/01/2028

A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

by CTG

in Metastatic Cancer

Other

New Jersey

Deadline:

06/01/2026

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

by CTG

in Metastatic Cancer, HPV-Related Carcinoma, HPV 16 Infection, Recurrence

Other

Maryland

Deadline:

10/18/2027

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

by CTG

in Cervical Cancer, Metastatic Cancer

Other

Texas

Deadline:

06/30/2026

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

by CTG

in Metastatic Cancer, Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Adenoid Cystic Carcinoma

Other

Massachusetts

Deadline:

04/12/2027

Prospective Validation of a Points Score System Predicting 30-day Survival

by CTG

in Metastatic Cancer

Other

Indiana

Deadline:

12/01/2026

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

by CTG

in Metastatic Cancer, Radiation Therapy

Other

New Jersey

Deadline:

12/30/2027

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

by CTG

in Metastatic Cancer, Urothelial Carcinoma

Other

Texas

Deadline:

09/30/2027

A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors

by CTG

in Breast Cancer, Metastatic Cancer, Advanced Cancer

Other

Connecticut

Deadline:

03/01/2026

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

by CTG

in Metastatic Cancer, Non-small Cell Lung Cancer, Advanced Solid Tumor, Cutaneous Melanoma

Other

Michigan

Deadline:

06/12/2026

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

by CTG

in Metastatic Cancer, Lung Cancer, Bladder Cancer, Melanoma Cancer, Renal Cancer

Other

Connecticut

Deadline:

10/01/2026

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

by CTG

in Metastatic Cancer

Other

California

Deadline:

03/31/2028

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

by CTG

in Unresectable Solid Tumor, Metastatic Cancer

Other

Missouri

Deadline:

05/31/2026

Advanced Planning for Online Accounts and Data

by CTG

in Metastatic Cancer, Terminal Cancer

Other

Colorado

Deadline:

05/01/2027

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

by CTG

in Metastatic Cancer, Advanced Cancer

Other

Connecticut

Deadline:

03/01/2026

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

by CTG

in Metastatic Cancer, Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor, Advanced Malignant Neoplasm

Other

California

Deadline:

07/14/2026

Definitive Radiation for High-Risk Spine Metastases

A Study of MGC026 in Participants With Advanced Solid Tumors

A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Prospective Validation of a Points Score System Predicting 30-day Survival

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

Advanced Planning for Online Accounts and Data

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Metastatic Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps